✦ LIBER ✦
Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia
✍ Scribed by Lundin, J; Porwit-MacDonald, A; Rossmann, E D; Karlsson, C; Edman, P; Rezvany, M R; Kimby, E; Österborg, A; Mellstedt, H
- Book ID
- 110055783
- Publisher
- Nature Publishing Group
- Year
- 2004
- Tongue
- English
- Weight
- 143 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.